Newsweek World
  • Business
  • Economics
  • Markets
  • Technology
GO ADD-FREE
  • Login
No Result
View All Result
  • Business
  • Economics
  • Markets
  • Technology
No Result
View All Result
Newsweek World
  • GO ADD-FREE
  • Login
Home Business

Drug Giants Offer No Commitments in Pricing Talks with US

Marco Sorenson by Marco Sorenson
June 9, 2025
in Business
Drug Giants Offer No Commitments in Pricing Talks with US

Pfizer CEO Albert Bourla confirmed that his company together with other drugmakers has met with the Trump administration about lowering U.S. drug prices yet no specific agreements have been reached.

The executive order signed by Trump during the previous month requires drug prices to match or be lower than what other wealthy nations pay which would lead to substantial cost reductions for American consumers. The Goldman Sachs Global Healthcare Conference heard from Bourla that the discussions with the administration remained friendly but failed to produce specific details.

Bourla stated that the administration initiated multiple meetings with companies yet they avoided discussing essential matters. The executive order contains a 30-day deadline but Bourla remains uncertain about what will develop from this period.

PhRMA under Bourla’s leadership has maintained its position of not knowing about any member discussions with the administration. The Department of Health and Human Services has stated that drugmakers must reduce their prices according to the “most favored nation” targets yet the companies have not established any official price targets.

The pharmaceutical industry faces increasing public demands for drug price reductions because Americans struggle with rising prescription medication expenses.

Tags: Pfizer
Previous Post

BlackRock Pushes Back on Antitrust Case by Republican States

Next Post

Smucker Profit Outlook Falls Short Amid Tariff, Cost Pressures

Related Posts

Boeing Outlook Raised by Fitch Amid Production
Business

Boeing Outlook Raised by Fitch Amid Production

Google Inks Deal to Buy Fusion Power from MIT Spinoff
Business

Google Inks Deal to Buy Fusion Power from MIT Spinoff

Apple Revises EU App Store Rules to Avoid Fines
Business

Apple Revises EU App Store Rules to Avoid Fines

Airline Stocks Gain on Hopes for Israel-Iran Ceasefire
Business

Airline Stocks Gain on Hopes for Israel-Iran Ceasefire

Amazon Bets on Premium Beauty to Offset Tariff Pressure
Business

Amazon Bets on Premium Beauty to Offset Tariff Pressure

Yum Brands Names CFO Chris Turner as New CEO
Business

Yum Brands Names CFO Chris Turner as New CEO

Next Post
Smucker Profit Outlook Falls Short Amid Tariff, Cost Pressures

Smucker Profit Outlook Falls Short Amid Tariff, Cost Pressures

Newsweek World
Linkedin Instagram X-twitter Facebook
Business >
Economics >
Markets >
Technology >

Company
About us
Authors

Company
About us
Authors

Contact
Contacts

Terms of Use
Terms & Conditions
Privacy Policy

Editions:
World
U.S. Edition
New York
Español
中文 (简体)
Português
Français
Italiano
Norsk
Svenska
Türkçe

Contact
Contacts

Terms of Use
Terms & Conditions
Privacy Policy

© 2025 Newsweek World.
All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business
  • Economics
  • Markets
  • Technology

© 2025 Newsweek World. All rights reserved.

  • Español
  • Português
  • 中文 (简体)
  • 日本語
  • Français
  • Italiano
  • Norsk
  • Svenska
  • Türkçe